Unknown

Dataset Information

0

Low nanomolar concentrations of Cucurbitacin-I induces G2/M phase arrest and apoptosis by perturbing redox homeostasis in gastric cancer cells in vitro and in vivo.


ABSTRACT: Cucurbitacin-I (Cu-I, also known as Elatericin B or JSI-124) is developed to inhibit constitutive and abnormal activation of STAT3 in many cancers, demonstrating a potent anticancer activity by targeting disruption of STAT3 function. Here, we for the first time systematically studied the underlying molecular mechanisms of Cu-I-induced gastric cancer cell death both in vitro and in vivo. In our study, we show that Cu-I markedly inhibits gastric cancer cell growth by inducing G2/M phase cell cycle arrest and apoptosis at low nanomolar concentrations via a STAT3-independent mechanism. Notably, Cu-I significantly decreases intracellular GSH/GSSG ratio by inhibiting NRF2 pathway to break cellular redox homeostasis, and subsequently induces the expression of GADD45? in a p53-independent manner, and activates JNK/p38 MAPK signaling. Interestingly, Cu-I-induced GADD45? and JNK/p38 MAPK signaling form a positive feedback loop and can be reciprocally regulated by each other. Therefore, the present study provides new insights into the mechanisms of antitumor effects of Cu-I, supporting Cu-I as an attractive therapeutic drug in gastric cancer by modulating the redox balance.

SUBMITTER: Deng C 

PROVIDER: S-EPMC5399186 | biostudies-literature | 2016 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Low nanomolar concentrations of Cucurbitacin-I induces G2/M phase arrest and apoptosis by perturbing redox homeostasis in gastric cancer cells in vitro and in vivo.

Deng C C   Zhang B B   Zhang S S   Duan C C   Cao Y Y   Kang W W   Yan H H   Ding X X   Zhou F F   Wu L L   Duan G G   Shen S S   Xu G G   Zhang W W   Chen M M   Huang S S   Zhang X X   Lv Y Y   Ling T T   Wang L L   Zou X X  

Cell death & disease 20160218


Cucurbitacin-I (Cu-I, also known as Elatericin B or JSI-124) is developed to inhibit constitutive and abnormal activation of STAT3 in many cancers, demonstrating a potent anticancer activity by targeting disruption of STAT3 function. Here, we for the first time systematically studied the underlying molecular mechanisms of Cu-I-induced gastric cancer cell death both in vitro and in vivo. In our study, we show that Cu-I markedly inhibits gastric cancer cell growth by inducing G2/M phase cell cycle  ...[more]

Similar Datasets

| S-EPMC7527894 | biostudies-literature
| S-EPMC4171705 | biostudies-literature
| S-EPMC3899331 | biostudies-literature
| S-EPMC3913755 | biostudies-literature
| S-EPMC6484297 | biostudies-literature
| S-EPMC5494816 | biostudies-other
| S-EPMC5564404 | biostudies-literature
2022-05-31 | GSE192359 | GEO
| S-EPMC5648535 | biostudies-literature
| S-EPMC4001305 | biostudies-literature